Risankizumab for refractory Crohn’s disease
Description
Dr Aditi Kumar, Deputy Editor of Frontline Gastroenterology and Consultant Gastroenterologist in Wolverhampton, UK interviews Dr Benjamin Zare, Gastroenterology registrar and a clinical research fellow undertaking his PhD at St Marks Academic Institute, London UK and Dr Mark Samaan who is a Consultant Gastroenterologist with a sub-specialist interest in IBD working at Guys and St Thomas NHS Foundation Trust in London, UK, on the paper 'Effectiveness of risankizumab induction and maintenance therapy for refractory Crohn’s disease: a real-world experience from a preapproval access programme and early access to medicines scheme' published online in Frontline Gastroenterology in October 2024.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
United States
